치 료저 항성 정 신분열증환자의 Valproic Acid 병합투여 효과

• 영문명: Adjunctive Effect of Valproic Acid in Treatment-Resistant Schizophrenic Patients
• 발행기관: 대한신경정신의학회
• 저자명: 이소영 김승현 이민수
• 간행물 정보: 『신경정신의학』제34권 제6호, 1910~1918쪽, 전체 9쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 1995.11.30

영문 초록

The purpose of this study has three aspects ： to see the clinical effect of adjunctive treatment of valproic acid to haloperidol in treatment-resistant schizophrenia, to see whether valproic acid has any influence on the plasma concentration of haloperidol, and to see whether there is any correlation between clinical change and the changes of the plasma concentration of these two drugs. Valproic acid(mean = 880mg/day) is administrated to 25 treatment-resistant schizophrenic patients, and among them 8 patients dropped out because of the side effect. There was significant improvement in the negative(p = 0.003) and general psychopathology scales(p = 0. 009) of PANSS. The mean concentration of valproic acid has decreased on the fourth week(p = 0.002), whereas the mean plasma concentration of haloperidol has increased on the second and fourth week of the study(p = 0.001). However, we could not find any correlation of between the plasma concentration of valproic acid and haloperidol. As conclusion, the adjunctive treatment of valproic acid to haloperidol in the treatment-resistant schizophrenia has improved in negative schizophrenic symptoms rather than in the positive symptoms. This suggests the usefulness of adjunctive treatment in terms of improving the overall quality of the life of the treatment- resistant schizophrenic patients

목차

서 론

연구대상 및 방법

결 과

고 찰

요 약

참고문헌

키워드

Treatment-resistant schizophrenia Valproic acid Haloperidol